Dai Ichi Life Insurance Company Ltd increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 8.9% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 163,914 shares of the healthcare conglomerate’s stock after purchasing an additional 13,432 shares during the period. UnitedHealth Group makes up about 0.7% of Dai Ichi Life Insurance Company Ltd’s investment portfolio, making the stock its 29th largest position. Dai Ichi Life Insurance Company Ltd’s holdings in UnitedHealth Group were worth $30,393,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Regal Wealth Group Inc. boosted its stake in UnitedHealth Group by 0.4% during the second quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock worth $138,000 after buying an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock valued at $204,000 after purchasing an additional 4 shares during the period. RB Capital Management LLC boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after purchasing an additional 7 shares during the period. Altfest L J & Co. Inc. boosted its stake in shares of UnitedHealth Group by 0.3% during the second quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock valued at $549,000 after purchasing an additional 10 shares during the period. Finally, Parkside Financial Bank & Trust boosted its stake in shares of UnitedHealth Group by 1.4% during the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after purchasing an additional 12 shares during the period. Institutional investors own 86.00% of the company’s stock.

A number of analysts have recently issued reports on UNH shares. Cantor Fitzgerald reissued an “overweight” rating and set a $208.00 target price on shares of UnitedHealth Group in a research note on Friday, July 21st. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and issued a $205.00 price objective (up from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $210.00 price objective (up from $190.00) on shares of UnitedHealth Group in a research note on Saturday, July 22nd. Three analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $216.65.

TRADEMARK VIOLATION WARNING: “Dai Ichi Life Insurance Company Ltd Increases Position in UnitedHealth Group Incorporated (UNH)” was published by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.dailypolitical.com/2017/11/17/dai-ichi-life-insurance-company-ltd-increases-position-in-unitedhealth-group-incorporated-unh.html.

UnitedHealth Group Incorporated (NYSE:UNH) opened at $211.13 on Friday. UnitedHealth Group Incorporated has a 52-week low of $148.56 and a 52-week high of $213.93. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. The stock has a market capitalization of $204,130.00, a P/E ratio of 22.05, a PEG ratio of 1.57 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same period in the prior year, the company earned $2.17 EPS. The firm’s revenue was up 8.7% compared to the same quarter last year. analysts expect that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be paid a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.42%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is currently 34.09%.

In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction on Monday, August 21st. The stock was sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the sale, the director now directly owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the completion of the sale, the insider now directly owns 195,625 shares of the company’s stock, valued at $38,755,268.75. The disclosure for this sale can be found here. Over the last three months, insiders sold 72,606 shares of company stock valued at $14,308,783. 0.89% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.